Quantcast

Latest therapy for depression Stories

2011-07-05 07:00:00

LOS ANGELES, July 5, 2011 /PRNewswire/ -- NeuroSigma, a Los Angeles-based neuromodulation company, today announced that a recent Phase I clinical trial revealed that external Trigeminal Nerve Stimulation (eTNS(TM)) increased regional cerebral blood flow in brain regions associated with depression and mood regulation. eTNS(TM) was shown to be a potential therapy for depression, with significant reductions in depression severity during the 8-week adjunctive treatment period. These...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related